Tyloxapol	NN	B-NP	O	Other	###	1	Tyloxapol	Tyloxapol	NN	NN	_	2	nsubj	_	_
inhibits	VBZ	B-VP	O	Other	###	2	inhibits	inhibits	VBZ	VBZ	_	0	root	_	_
NF-kappa	NN	B-NP	B-protein	Other	###	3	NF-kappa	NF-kappa	NN	NN	_	4	compound	_	_
B	NN	I-NP	I-protein	Other	###	4	B	B	NN	NN	_	2	dobj	_	_
and	CC	O	O	Other	###	5	and	and	CC	CC	_	4	cc	_	_
cytokine	NN	B-NP	B-protein	Other	###	6	cytokine	cytokine	NN	NN	_	4	conj	_	_
release	NN	I-NP	O	Other	###	7	release	release	NN	NN	_	2	dobj	_	_
,	,	O	O	Other	###	8	,	,	,	,	_	2	punct	_	_
scavenges	VBZ	B-VP	O	Other	###	9	scavenges	scavenges	VBZ	VBZ	_	2	conj	_	_
HOCI	NN	B-NP	B-protein	Other	###	10	HOCI	HOCI	NN	NN	_	9	dobj	_	_
,	,	O	O	Other	###	11	,	,	,	,	_	2	punct	_	_
and	CC	O	O	Other	###	12	and	and	CC	CC	_	2	cc	_	_
reduces	VBZ	B-VP	O	Other	###	13	reduces	reduces	VBZ	VBZ	_	2	conj	_	_
viscosity	NN	B-NP	O	Other	###	14	viscosity	viscosity	NN	NN	_	13	dobj	_	_
of	IN	B-PP	O	Other	###	15	of	of	IN	IN	_	18	case	_	_
cystic	JJ	B-NP	O	Other	###	16	cystic	cystic	JJ	JJ	_	18	amod	_	_
fibrosis	NN	I-NP	O	Other	###	17	fibrosis	fibrosis	NN	NN	_	18	compound	_	_
sputum	NN	I-NP	O	Other	###	18	sputum	sputum	NN	NN	_	14	nmod	_	_
.	.	O	O	Other	###	19	.	.	.	.	_	2	punct	_	_

Cystic	JJ	B-NP	O	Other	###	1	Cystic	Cystic	JJ	JJ	_	2	amod	_	_
fibrosis	NN	I-NP	O	Other	###	2	fibrosis	fibrosis	NN	NN	_	6	compound	_	_
(	(	O	O	Other	###	3	(	(	(	(	_	4	punct	_	_
CF	NN	B-NP	O	Other	###	4	CF	CF	NN	NN	_	2	appos	_	_
)	)	O	O	Other	###	5	)	)	)	)	_	4	punct	_	_
patients	NNS	B-NP	O	Other	###	6	patients	patients	NNS	NNS	_	7	nsubj	_	_
develop	VBP	B-VP	O	Other	###	7	develop	develop	VBP	VBP	_	0	root	_	_
progressive	JJ	B-NP	O	Other	###	8	progressive	progressive	JJ	JJ	_	14	amod	_	_
cytokine	JJ	I-NP	O	Other	###	9	cytokine	cytokine	JJ	JJ	_	14	compound	_	_
-	-	O	O	Other	###	10	-	-	-	-	_	9	punct	_	_
mediated	JJ	I-NP	O	Other	###	11	mediated	mediated	JJ	JJ	_	14	amod	_	_
inflammatory	JJ	I-NP	O	Other	###	12	inflammatory	inflammatory	JJ	JJ	_	14	amod	_	_
lung	NN	I-NP	O	Other	###	13	lung	lung	NN	NN	_	14	compound	_	_
disease	NN	I-NP	O	Other	###	14	disease	disease	NN	NN	_	7	dobj	_	_
,	,	O	O	Other	###	15	,	,	,	,	_	14	punct	_	_
with	IN	B-PP	O	Other	###	16	with	with	IN	IN	_	18	case	_	_
abundant	JJ	B-NP	O	Other	###	17	abundant	abundant	JJ	JJ	_	18	amod	_	_
production	NN	I-NP	O	Other	###	18	production	production	NN	NN	_	7	nmod	_	_
of	IN	B-PP	O	Other	###	19	of	of	IN	IN	_	30	case	_	_
thick	JJ	B-NP	O	Other	###	20	thick	thick	JJ	JJ	_	30	amod	_	_
,	,	I-NP	O	Other	###	21	,	,	,	,	_	20	punct	_	_
tenacious	JJ	I-NP	O	Other	###	22	tenacious	tenacious	JJ	JJ	_	20	dep	_	_
,	,	I-NP	O	Other	###	23	,	,	,	,	_	20	punct	_	_
protease	NN	I-NP	B-protein	Other	###	24	protease	protease	NN	NN	_	20	dep	_	_
-	-	O	O	Other	###	25	-	-	-	-	_	24	punct	_	_
and	CC	I-NP	O	Other	###	26	and	and	CC	CC	_	20	cc	_	_
oxidant-rich	JJ	I-NP	O	Other	###	27	oxidant-rich	oxidant-rich	JJ	JJ	_	20	conj	_	_
purulent	JJ	I-NP	O	Other	###	28	purulent	purulent	JJ	JJ	_	30	amod	_	_
airway	NN	I-NP	O	Other	###	29	airway	airway	NN	NN	_	30	compound	_	_
secretions	NNS	I-NP	O	Other	###	30	secretions	secretions	NNS	NNS	_	18	nmod	_	_
that	WDT	B-NP	O	Other	###	31	that	that	WDT	WDT	_	33	nsubj	_	_
are	VBP	B-VP	O	Other	###	32	are	are	VBP	VBP	_	33	cop	_	_
difficult	JJ	B-ADJP	O	Other	###	33	difficult	difficult	JJ	JJ	_	30	acl:relcl	_	_
to	TO	B-VP	O	Other	###	34	to	to	TO	TO	_	35	mark	_	_
clear	VB	I-VP	O	Other	###	35	clear	clear	VB	VB	_	33	ccomp	_	_
even	RB	B-ADVP	O	Other	###	36	even	even	RB	RB	_	38	advmod	_	_
with	IN	B-PP	O	Other	###	37	with	with	IN	IN	_	38	case	_	_
physiotherapy	NN	B-NP	O	Other	###	38	physiotherapy	physiotherapy	NN	NN	_	35	nmod	_	_
.	.	O	O	Other	###	39	.	.	.	.	_	7	punct	_	_

In	IN	B-PP	O	Other	###	1	In	In	IN	IN	_	3	case	_	_
the	DT	B-NP	O	Other	###	2	the	the	DT	DT	_	3	det	_	_
search	NN	I-NP	O	Other	###	3	search	search	NN	NN	_	11	nmod	_	_
for	IN	B-PP	O	Other	###	4	for	for	IN	IN	_	7	case	_	_
a	DT	B-NP	O	Other	###	5	a	a	DT	DT	_	7	det	_	_
potential	JJ	I-NP	O	Other	###	6	potential	potential	JJ	JJ	_	7	amod	_	_
treatment	NN	I-NP	O	Other	###	7	treatment	treatment	NN	NN	_	3	nmod	_	_
,	,	O	O	Other	###	8	,	,	,	,	_	11	punct	_	_
we	PRP	B-NP	O	Other	###	9	we	we	PRP	PRP	_	11	nsubj	_	_
have	VBP	B-VP	O	Other	###	10	have	have	VBP	VBP	_	11	aux	_	_
tested	VBN	I-VP	O	Other	###	11	tested	tested	VBN	VBN	_	0	root	_	_
tyloxapol	NN	B-NP	O	Other	###	12	tyloxapol	tyloxapol	NN	NN	_	11	dobj	_	_
,	,	O	O	Other	###	13	,	,	,	,	_	12	punct	_	_
an	DT	B-NP	O	Other	###	14	an	an	DT	DT	_	19	det	_	_
alkylaryl	NN	I-NP	O	Other	###	15	alkylaryl	alkylaryl	NN	NN	_	19	compound	_	_
polyether	NN	I-NP	O	Other	###	16	polyether	polyether	NN	NN	_	19	compound	_	_
alcohol	NN	I-NP	O	Other	###	17	alcohol	alcohol	NN	NN	_	19	compound	_	_
polymer	NN	I-NP	O	Other	###	18	polymer	polymer	NN	NN	_	19	compound	_	_
detergent	NN	I-NP	O	Other	###	19	detergent	detergent	NN	NN	_	12	appos	_	_
previously	RB	B-VP	O	Other	###	20	previously	previously	RB	RB	_	21	advmod	_	_
used	VBN	I-VP	O	Other	###	21	used	used	VBN	VBN	_	19	acl	_	_
as	IN	B-PP	O	Other	###	22	as	as	IN	IN	_	25	case	_	_
a	DT	B-NP	O	Other	###	23	a	a	DT	DT	_	25	det	_	_
mucolytic	JJ	I-NP	O	Other	###	24	mucolytic	mucolytic	JJ	JJ	_	25	amod	_	_
agent	NN	I-NP	O	Other	###	25	agent	agent	NN	NN	_	21	nmod	_	_
in	IN	B-PP	O	Other	###	26	in	in	IN	IN	_	29	case	_	_
adult	JJ	B-NP	O	Other	###	27	adult	adult	JJ	JJ	_	29	amod	_	_
chronic	JJ	I-NP	O	Other	###	28	chronic	chronic	JJ	JJ	_	29	amod	_	_
bronchitis	NN	I-NP	O	Other	###	29	bronchitis	bronchitis	NN	NN	_	25	nmod	_	_
.	.	O	O	Other	###	30	.	.	.	.	_	11	punct	_	_

Tyloxapol	NN	B-NP	O	Other	###	1	Tyloxapol	Tyloxapol	NN	NN	_	2	nsubj	_	_
inhibits	VBZ	B-VP	O	Other	###	2	inhibits	inhibits	VBZ	VBZ	_	0	root	_	_
activation	NN	B-NP	O	Other	###	3	activation	activation	NN	NN	_	2	dobj	_	_
of	IN	B-PP	O	Other	###	4	of	of	IN	IN	_	7	case	_	_
the	DT	B-NP	O	Other	###	5	the	the	DT	DT	_	7	det	_	_
transcription	NN	I-NP	B-protein	Other	###	6	transcription	transcription	NN	NN	_	7	compound	_	_
factor	NN	I-NP	I-protein	Other	###	7	factor	factor	NN	NN	_	3	nmod	_	_
nuclear	JJ	I-NP	B-protein	Other	###	8	nuclear	nuclear	JJ	JJ	_	10	amod	_	_
factor-kappa	NN	I-NP	I-protein	Other	###	9	factor-kappa	factor-kappa	NN	NN	_	10	compound	_	_
B	NN	I-NP	I-protein	Other	###	10	B	B	NN	NN	_	7	dep	_	_
(	(	O	O	Other	###	11	(	(	(	(	_	13	punct	_	_
NK-kappa	NN	B-NP	B-protein	Other	###	12	NK-kappa	NK-kappa	NN	NN	_	13	compound	_	_
B	NN	I-NP	I-protein	Other	###	13	B	B	NN	NN	_	10	appos	_	_
)	)	O	O	Other	###	14	)	)	)	)	_	13	punct	_	_
,	,	O	O	Other	###	15	,	,	,	,	_	2	punct	_	_
reduces	VBZ	B-VP	O	Other	###	16	reduces	reduces	VBZ	VBZ	_	2	conj	_	_
resting	VBG	B-NP	O	Other	###	17	resting	resting	VBG	VBG	_	18	amod	_	_
secretion	NN	I-NP	O	Other	###	18	secretion	secretion	NN	NN	_	16	dobj	_	_
of	IN	B-PP	O	Other	###	19	of	of	IN	IN	_	21	case	_	_
the	DT	B-NP	O	Other	###	20	the	the	DT	DT	_	21	det	_	_
cytokine	NN	I-NP	B-protein	Other	###	21	cytokine	cytokine	NN	NN	_	18	nmod	_	_
interleukin-8	NN	I-NP	B-protein	B-Protein	###	22	interleukin-8	interleukin-8	NN	NN	_	21	dep	_	_
(	(	O	O	Other	###	23	(	(	(	(	_	24	punct	_	_
IL-8	NN	B-NP	B-protein	B-Protein	###	24	IL-8	IL-8	NN	NN	_	22	appos	_	_
)	)	O	O	Other	###	25	)	)	)	)	_	24	punct	_	_
in	IN	B-PP	O	Other	###	26	in	in	IN	IN	_	29	case	_	_
cultured	VBN	B-NP	B-cell_line	Other	###	27	cultured	cultured	VBN	VBN	_	29	amod	_	_
human	JJ	I-NP	I-cell_line	Other	###	28	human	human	JJ	JJ	_	29	amod	_	_
monocytes	NNS	I-NP	I-cell_line	Other	###	29	monocytes	monocytes	NNS	NNS	_	21	nmod	_	_
,	,	O	O	Other	###	30	,	,	,	,	_	2	punct	_	_
and	CC	O	O	Other	###	31	and	and	CC	CC	_	2	cc	_	_
inhibits	VBZ	B-VP	O	Other	###	32	inhibits	inhibits	VBZ	VBZ	_	2	conj	_	_
lipopolysaccharide	NN	B-NP	O	Other	###	33	lipopolysaccharide	lipopolysaccharide	NN	NN	_	38	nmod:npmod	_	_
(	(	O	O	Other	###	34	(	(	(	(	_	38	punct	_	_
LPS	NN	B-NP	O	Other	###	35	LPS	LPS	NN	NN	_	38	nmod:npmod	_	_
)	)	O	O	Other	###	36	)	)	)	)	_	38	punct	_	_
-	-	O	O	Other	###	37	-	-	-	-	_	38	punct	_	_
stimulated	JJ	B-NP	O	Other	###	38	stimulated	stimulated	JJ	JJ	_	39	amod	_	_
release	NN	I-NP	O	Other	###	39	release	release	NN	NN	_	32	dobj	_	_
of	IN	B-PP	O	Other	###	40	of	of	IN	IN	_	43	case	_	_
tumor	NN	B-NP	B-protein	B-Protein	###	41	tumor	tumor	NN	NN	_	43	compound	_	_
necrosis	NN	I-NP	I-protein	I-Protein	###	42	necrosis	necrosis	NN	NN	_	43	compound	_	_
factor-alpha	NN	I-NP	I-protein	I-Protein	###	43	factor-alpha	factor-alpha	NN	NN	_	39	nmod	_	_
(	(	O	O	Other	###	44	(	(	(	(	_	45	punct	_	_
TNF-alpha	NN	B-NP	B-protein	B-Protein	###	45	TNF-alpha	TNF-alpha	NN	NN	_	43	appos	_	_
)	)	O	O	Other	###	46	)	)	)	)	_	45	punct	_	_
,	,	O	O	Other	###	47	,	,	,	,	_	43	punct	_	_
IL-1	NN	B-NP	B-protein	B-Protein	###	48	IL-1	IL-1	NN	NN	_	49	compound	_	_
beta	NN	I-NP	I-protein	I-Protein	###	49	beta	beta	NN	NN	_	43	conj	_	_
,	,	O	O	Other	###	50	,	,	,	,	_	43	punct	_	_
IL-6	NN	B-NP	B-protein	B-Protein	###	51	IL-6	IL-6	NN	NN	_	43	conj	_	_
,	,	O	O	Other	###	52	,	,	,	,	_	43	punct	_	_
IL-8	NN	B-NP	B-protein	B-Protein	###	53	IL-8	IL-8	NN	NN	_	43	conj	_	_
,	,	O	O	Other	###	54	,	,	,	,	_	43	punct	_	_
granulocyte-macrophage	NN	I-NP	I-protein	B-Protein	###	55	granulocyte-macrophage	granulocyte-macrophage	NN	NN	_	57	amod	_	_
colony-stimulating	NN	I-NP	I-protein	I-Protein	###	56	colony-stimulating	colony-stimulating	NN	NN	_	57	amod	_	_
factor	NN	I-NP	I-protein	I-Protein	###	57	factor	factor	NN	NN	_	43	conj	_	_
(	(	O	O	Other	###	58	(	(	(	(	_	59	punct	_	_
GM-CSF	NN	B-NP	B-protein	B-Protein	###	59	GM-CSF	GM-CSF	NN	NN	_	57	appos	_	_
)	)	O	O	Other	###	60	)	)	)	)	_	59	punct	_	_
,	,	O	O	Other	###	61	,	,	,	,	_	43	punct	_	_
and	CC	O	O	Other	###	62	and	and	CC	CC	_	43	cc	_	_
the	DT	B-NP	O	Other	###	63	the	the	DT	DT	_	64	det	_	_
eiconsanoids	NNS	I-NP	O	Other	###	64	eiconsanoids	eiconsanoids	NNS	NNS	_	43	conj	_	_
thromboxane	NN	I-NP	O	Other	###	65	thromboxane	thromboxane	NN	NN	_	66	compound	_	_
A2	NN	I-NP	O	Other	###	66	A2	A2	NN	NN	_	64	dep	_	_
and	CC	O	O	Other	###	67	and	and	CC	CC	_	66	cc	_	_
leukotriene	NN	B-NP	O	Other	###	68	leukotriene	leukotriene	NN	NN	_	69	compound	_	_
B4	NN	I-NP	O	Other	###	69	B4	B4	NN	NN	_	66	conj	_	_
(	(	O	O	Other	###	70	(	(	(	(	_	71	punct	_	_
LTB4	NN	B-NP	O	Other	###	71	LTB4	LTB4	NN	NN	_	69	appos	_	_
)	)	O	O	Other	###	72	)	)	)	)	_	71	punct	_	_
.	.	O	O	Other	###	73	.	.	.	.	_	2	punct	_	_

We	PRP	B-NP	O	Other	###	1	We	We	PRP	PRP	_	4	nsubj	_	_
have	VBP	B-VP	O	Other	###	2	have	have	VBP	VBP	_	4	aux	_	_
previously	RB	I-VP	O	Other	###	3	previously	previously	RB	RB	_	4	advmod	_	_
shown	VBN	I-VP	O	Other	###	4	shown	shown	VBN	VBN	_	0	root	_	_
that	IN	B-SBAR	O	Other	###	5	that	that	IN	IN	_	10	mark	_	_
tyloxapol	NN	B-NP	O	Other	###	6	tyloxapol	tyloxapol	NN	NN	_	10	nsubj	_	_
is	VBZ	B-VP	O	Other	###	7	is	is	VBZ	VBZ	_	10	cop	_	_
a	DT	B-NP	O	Other	###	8	a	a	DT	DT	_	10	det	_	_
potent	JJ	I-NP	O	Other	###	9	potent	potent	JJ	JJ	_	10	amod	_	_
antioxidant	NN	I-NP	O	Other	###	10	antioxidant	antioxidant	NN	NN	_	4	ccomp	_	_
for	IN	B-PP	O	Other	###	11	for	for	IN	IN	_	13	case	_	_
hydroxyl	NN	B-NP	O	Other	###	12	hydroxyl	hydroxyl	NN	NN	_	13	compound	_	_
radicals	NNS	I-NP	O	Other	###	13	radicals	radicals	NNS	NNS	_	10	nmod	_	_
(	(	O	O	Other	###	14	(	(	(	(	_	15	punct	_	_
OH	NN	B-NP	O	Other	###	15	OH	OH	NN	NN	_	13	appos	_	_
)	)	O	O	Other	###	16	)	)	)	)	_	15	punct	_	_
.	.	O	O	Other	###	17	.	.	.	.	_	4	punct	_	_

Tyloxapol	NN	B-NP	O	Other	###	1	Tyloxapol	Tyloxapol	NN	NN	_	12	nsubj	_	_
(	(	O	O	Other	###	2	(	(	(	(	_	7	punct	_	_
0.05	CD	B-NP	O	Other	###	3	0.05	0.05	CD	CD	_	5	compound	_	_
to	TO	I-NP	O	Other	###	4	to	to	TO	TO	_	5	dep	_	_
0.1	CD	I-NP	O	Other	###	5	0.1	0.1	CD	CD	_	6	dep	_	_
%	NN	I-NP	O	Other	###	6	%	%	NN	NN	_	7	amod	_	_
wt	NN	I-NP	O	Other	###	7	wt	wt	NN	NN	_	1	dep	_	_
/	/	O	O	Other	###	8	/	/	/	/	_	7	punct	_	_
vol	NN	I-NP	O	Other	###	9	vol	vol	NN	NN	_	7	appos	_	_
)	)	O	O	Other	###	10	)	)	)	)	_	7	punct	_	_
effectively	RB	B-VP	O	Other	###	11	effectively	effectively	RB	RB	_	12	advmod	_	_
scavenges	VBZ	I-VP	O	Other	###	12	scavenges	scavenges	VBZ	VBZ	_	0	root	_	_
the	DT	B-NP	O	Other	###	13	the	the	DT	DT	_	16	det	_	_
oxidant	JJ	I-NP	O	Other	###	14	oxidant	oxidant	JJ	JJ	_	16	amod	_	_
hypochlorous	JJ	I-NP	O	Other	###	15	hypochlorous	hypochlorous	JJ	JJ	_	16	amod	_	_
acid	NN	I-NP	O	Other	###	16	acid	acid	NN	NN	_	12	dobj	_	_
(	(	O	O	Other	###	17	(	(	(	(	_	18	punct	_	_
HOCl	NN	B-NP	O	Other	###	18	HOCl	HOCl	NN	NN	_	16	dep	_	_
;	:	O	O	Other	###	19	;	;	:	:	_	18	punct	_	_
1	CD	B-NP	O	Other	###	20	1	1	CD	CD	_	22	compound	_	_
to	TO	I-NP	O	Other	###	21	to	to	TO	TO	_	22	dep	_	_
7.5	CD	I-NP	O	Other	###	22	7.5	7.5	CD	CD	_	23	nummod	_	_
mM	NN	I-NP	O	Other	###	23	mM	mM	NN	NN	_	18	dep	_	_
)	)	O	O	Other	###	24	)	)	)	)	_	18	punct	_	_
in	FW	B-ADVP	O	Other	###	25	in	in	FW	FW	_	26	compound	_	_
vitro	FW	I-ADVP	O	Other	###	26	vitro	vitro	FW	FW	_	12	advmod	_	_
,	,	O	O	Other	###	27	,	,	,	,	_	12	punct	_	_
and	CC	O	O	Other	###	28	and	and	CC	CC	_	12	cc	_	_
protects	VBZ	B-VP	O	Other	###	29	protects	protects	VBZ	VBZ	_	12	conj	_	_
from	IN	B-PP	O	Other	###	30	from	from	IN	IN	_	35	case	_	_
HOCl	JJ	B-NP	O	Other	###	31	HOCl	HOCl	JJ	JJ	_	35	amod	_	_
-	-	O	O	Other	###	32	-	-	-	-	_	35	punct	_	_
mediated	JJ	B-NP	O	Other	###	33	mediated	mediated	JJ	JJ	_	31	dep	_	_
lung	NN	I-NP	O	Other	###	34	lung	lung	NN	NN	_	35	compound	_	_
injury	NN	I-NP	O	Other	###	35	injury	injury	NN	NN	_	29	nmod	_	_
in	IN	B-PP	O	Other	###	36	in	in	IN	IN	_	37	case	_	_
rats	NNS	B-NP	O	Other	###	37	rats	rats	NNS	NNS	_	35	nmod	_	_
.	.	O	O	Other	###	38	.	.	.	.	_	12	punct	_	_

Tyloxapol	NN	B-NP	O	Other	###	1	Tyloxapol	Tyloxapol	NN	NN	_	3	nsubj	_	_
also	RB	B-ADVP	O	Other	###	2	also	also	RB	RB	_	3	advmod	_	_
reduces	VBZ	B-VP	O	Other	###	3	reduces	reduces	VBZ	VBZ	_	0	root	_	_
the	DT	B-NP	O	Other	###	4	the	the	DT	DT	_	5	det	_	_
viscosity	NN	I-NP	O	Other	###	5	viscosity	viscosity	NN	NN	_	3	dobj	_	_
of	IN	B-PP	O	Other	###	6	of	of	IN	IN	_	8	case	_	_
CF	NN	B-NP	O	Other	###	7	CF	CF	NN	NN	_	8	compound	_	_
sputum	NN	I-NP	O	Other	###	8	sputum	sputum	NN	NN	_	5	nmod	_	_
(	(	O	O	Other	###	9	(	(	(	(	_	3	punct	_	_
from	IN	B-PP	O	Other	###	10	from	from	IN	IN	_	11	case	_	_
463	CD	B-NP	O	Other	###	11	463	463	CD	CD	_	18	nummod	_	_
+/-	SYM	I-NP	O	Other	###	12	+/-	+/-	SYM	SYM	_	11	cc	_	_
133	CD	I-NP	O	Other	###	13	133	133	CD	CD	_	11	conj	_	_
to	TO	I-NP	O	Other	###	14	to	to	TO	TO	_	15	case	_	_
128	CD	I-NP	O	Other	###	15	128	128	CD	CD	_	11	conj	_	_
+/-	SYM	I-NP	O	Other	###	16	+/-	+/-	SYM	SYM	_	15	cc	_	_
52	CD	I-NP	O	Other	###	17	52	52	CD	CD	_	15	conj	_	_
centipoise	NN	I-NP	O	Other	###	18	centipoise	centipoise	NN	NN	_	3	nmod	_	_
)	)	O	O	Other	###	19	)	)	)	)	_	3	punct	_	_
.	.	O	O	Other	###	20	.	.	.	.	_	3	punct	_	_

We	PRP	B-NP	O	Other	###	1	We	We	PRP	PRP	_	2	nsubj	_	_
conclude	VBP	B-VP	O	Other	###	2	conclude	conclude	VBP	VBP	_	0	root	_	_
that	IN	B-SBAR	O	Other	###	3	that	that	IN	IN	_	7	mark	_	_
tyloxapol	NN	B-NP	O	Other	###	4	tyloxapol	tyloxapol	NN	NN	_	7	nsubj	_	_
is	VBZ	B-VP	O	Other	###	5	is	is	VBZ	VBZ	_	7	cop	_	_
potentially	RB	B-ADJP	O	Other	###	6	potentially	potentially	RB	RB	_	7	advmod	_	_
useful	JJ	I-ADJP	O	Other	###	7	useful	useful	JJ	JJ	_	2	ccomp	_	_
as	IN	B-PP	O	Other	###	8	as	as	IN	IN	_	12	case	_	_
a	DT	B-NP	O	Other	###	9	a	a	DT	DT	_	12	det	_	_
new	JJ	I-NP	O	Other	###	10	new	new	JJ	JJ	_	12	amod	_	_
antiinflammatory	JJ	I-NP	O	Other	###	11	antiinflammatory	antiinflammatory	JJ	JJ	_	12	amod	_	_
therapy	NN	I-NP	O	Other	###	12	therapy	therapy	NN	NN	_	7	nmod	_	_
for	IN	B-PP	O	Other	###	13	for	for	IN	IN	_	16	case	_	_
CF	NN	B-NP	O	Other	###	14	CF	CF	NN	NN	_	16	compound	_	_
lung	NN	I-NP	O	Other	###	15	lung	lung	NN	NN	_	16	compound	_	_
disease	NN	I-NP	O	Other	###	16	disease	disease	NN	NN	_	12	nmod	_	_
,	,	O	O	Other	###	17	,	,	,	,	_	7	punct	_	_
and	CC	O	O	Other	###	18	and	and	CC	CC	_	7	cc	_	_
could	MD	B-VP	O	Other	###	19	could	could	MD	MD	_	21	aux	_	_
possibly	RB	I-VP	O	Other	###	20	possibly	possibly	RB	RB	_	21	advmod	_	_
promote	VB	I-VP	O	Other	###	21	promote	promote	VB	VB	_	7	conj	_	_
clearance	NN	B-NP	O	Other	###	22	clearance	clearance	NN	NN	_	21	dobj	_	_
of	IN	B-PP	O	Other	###	23	of	of	IN	IN	_	24	case	_	_
secretions	NNS	B-NP	O	Other	###	24	secretions	secretions	NNS	NNS	_	22	nmod	_	_
in	IN	B-PP	O	Other	###	25	in	in	IN	IN	_	28	case	_	_
the	DT	B-NP	O	Other	###	26	the	the	DT	DT	_	28	det	_	_
CF	NN	I-NP	O	Other	###	27	CF	CF	NN	NN	_	28	compound	_	_
airway	NN	I-NP	O	Other	###	28	airway	airway	NN	NN	_	22	nmod	_	_
.	.	O	O	Other	###	29	.	.	.	.	_	2	punct	_	_

